The Mycoplasma Testing Market is undergoing a structural transformation driven by...Read More
Posted On: Jun-2026 | Categories : Healthcare
The Animal Stem Cell Therapy Market should not be viewed solely as a regenerative medicine segment, as its primary commercial value is increasingly positioned at th...Read More
The Autologous Cell Therapy Market is entering a sharper strategic phase as autoimmune disease moves from academic proof-of-concept to industry-backed clinical development....Read More
The Global Cancer Gene Therapy Market is projected to grow at a CAGR of 25.8%, rising from USD 2.9 billion in 2024 to USD 10.5 billion by 2030.
Cancer gene therapy is...Read More
The FDA approval of pivekimab sunirine-pvzy for adult blastic plasmacytoid dendritic cell neoplasm extends beyond a rare-disease indication update. It strengthens the therapeutic po...Read More
Novel T-cell immunotherapy is entering a new phase because the field is no longer ...Read More
The Global Engineered Cytokine Immunotherapy Market...Read More
The Global Cancer Photodynamic Therapy Market is pr...Read More
Enzyme replacement therapy has already transformed the treatment landscape in Pompe disease, with its clinical role now well established. The more critical consideration is whether ERT ca...Read More
Dopamine agonists are not a new drug class looking for its first commercial proof. They are already embedded in neurology and endocrine practice through therapies such as pramipexole, ropinirole, ...Read More